Nuestros recursos

In our conversations with trial sponsors, ObvioHealth often tackles common misconceptions about decentralized clinical trials (DCTs). These myths hinder our industry’s evolution by keeping sponsors from designing optimal trials that deliver better data with higher retention and compliance rates.

Leveraging real-world examples from the first fully virtual clinical trial in the urogynecology space, our presenters discuss the ways in which digital solutions have helped to increase patient recruitment, engagement, and completion rates.

Listen in as industry leaders discuss how to execute successful DCTs by building a seamless patient experience from enrollment to trial completion.

One of the keys to optimizing ePRO is deploying artificial intelligence (AI) to support human participants and clinical teams.

The unique challenges associated with women’s health, and women as a cohort, make clinical research in this sector especially difficult. DCTs are helping to tackle the obstacles.

eConsent can mitigate these shortcomings by providing flexibility and engagement that empower patients with information and sponsors with data integrity.

Diversity in clinical trials is a scientific imperative, a moral and ethical necessity—and a longstanding challenge in clinical research. DCTs are evolving the industry status quo.

ObvioHealth, a leading global Virtual Research Organization (VRO) pioneering end-to-end decentralized clinical trial solutions, announces the development of two novel digital instruments to increase accuracy and reduce patient/caregiver burden in pediatric clinical trials.